INTENSIVE HEPATOLOGICAL STUDIES USING CARPHENAZINE
Abstract
Nine severely deteriorated chronic schizophrenic patients were treated continuously for 115 days with carphenazine in daily doses that were initiated at 25 mg. and ultimately raised to 100, 150, 200 and 300 mg. Three showed moderate and 5 slight overall reduction in symptoms.
The findings in bi-weekly transaminase determinations and weekly complete blood counts and urinalyses remained within normal limits for all patients throughout treatment. According to these preliminary data, carphenazine appears to be a safe agent for long term antipsychotic treatment.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
